|
GFL
|
Industrials |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$14.0B
|
$31.04
|
-2.5%
|
-0.1%
|
+2.0%
|
+3.2%
|
+2.5%
|
-4.4%
|
|
BBY
|
Consumer Cyclical |
Raymond James |
Downgrade
|
Strong Buy
→
Outperform
|
—
|
$12.9B
|
$102.94
|
-1.8%
|
-2.5%
|
+1.3%
|
+0.8%
|
-2.1%
|
-2.1%
|
|
IRTC
|
Healthcare |
Colliers Securities |
Downgrade
|
Buy
→
Neutral
|
—
|
$3.6B
|
$147.73
|
-1.4%
|
+8.9%
|
-5.0%
|
-2.6%
|
-3.8%
|
-0.1%
|
|
VRRM
|
Technology |
Morgan Stanley |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$2.1B
|
$14.12
|
-1.3%
|
+0.9%
|
+3.0%
|
-5.4%
|
-0.4%
|
-1.0%
|
|
AGIO
|
Healthcare |
SVB Leerink |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$1.7B
|
$50.29
|
-5.3%
|
-5.7%
|
+0.1%
|
+3.0%
|
-5.8%
|
+2.7%
|
|
USPH
|
Healthcare |
Barrington Research |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$935M
|
$116.31
|
-0.2%
|
+0.8%
|
-0.8%
|
-2.4%
|
-2.4%
|
-0.1%
|
|
SLRC
|
Financial Services |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$707M
|
$19.14
|
-0.4%
|
+1.1%
|
-0.2%
|
-0.9%
|
+0.5%
|
-1.1%
|
|
MGPI
|
Consumer Defensive |
Truist |
Downgrade
|
Buy
→
Hold
|
—
|
$380M
|
$66.43
|
-4.8%
|
-3.8%
|
+3.6%
|
-2.4%
|
-2.5%
|
-2.4%
|
|
WSBF
|
Financial Services |
Piper Sandler |
Downgrade
|
Overweight
→
Neutral
|
—
|
$325M
|
$20.21
|
-3.5%
|
-3.9%
|
+0.8%
|
+0.7%
|
+3.5%
|
-0.6%
|
|
FATE
|
Healthcare |
Wedbush |
Downgrade
|
Outperform
→
Neutral
|
—
|
$225M
|
$86.27
|
+2.8%
|
+4.0%
|
+7.7%
|
-0.7%
|
-7.7%
|
-6.0%
|
|
EDIT
|
Healthcare |
Truist |
Downgrade
|
Buy
→
Hold
|
—
|
$218M
|
$44.76
|
+0.7%
|
-2.0%
|
+6.9%
|
-2.6%
|
-5.6%
|
-6.4%
|
|
CLW
|
Basic Materials |
RBC Capital |
Downgrade
|
Outperform
→
Sector Perform
|
—
|
$217M
|
$41.55
|
-9.9%
|
-15.7%
|
+1.7%
|
+2.6%
|
-0.0%
|
-0.5%
|
|
VYGR
|
Healthcare |
Baird |
Downgrade
|
Outperform
→
Neutral
|
—
|
$204M
|
$6.23
|
-5.3%
|
-9.0%
|
+5.3%
|
-5.0%
|
-2.3%
|
+0.7%
|